相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas
Anan Yin et al.
ONCOTARGET (2017)
Translating Cancer Genomes and Transcriptomes for Precision Oncology
Sameek Roychowdhury et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy
Michele Maio et al.
CLINICAL CANCER RESEARCH (2015)
TRIM38 Negatively Regulates TLR3/4-Mediated Innate Immune and Inflammatory Responses by Two Sequential and Distinct Mechanisms
Ming-Ming Hu et al.
JOURNAL OF IMMUNOLOGY (2015)
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma
Sebastian Kurscheid et al.
GENOME BIOLOGY (2015)
Trim58 Degrades Dynein and Regulates Terminal Erythropoiesis
Christopher S. Thom et al.
DEVELOPMENTAL CELL (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis
An-an Yin et al.
PLOS ONE (2014)
Genome-Wide Methylation Analyses in Glioblastoma Multiforme
Rose K. Lai et al.
PLOS ONE (2014)
TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3
Ming-Ming Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors
Winston Timp et al.
GENOME MEDICINE (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
Andrew E. Teschendorff et al.
BIOINFORMATICS (2013)
Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma
Wei Zhang et al.
CANCER LETTERS (2013)
A DNA Methylation Prognostic Signature of Glioblastoma: Identification of NPTX2-PTEN-NF-κB Nexus
Sudhanshu Shukla et al.
CANCER RESEARCH (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
The treatment of glioblastomas: A systematic update on clinical Phase III trials
An-an Yin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
Pierre Bady et al.
ACTA NEUROPATHOLOGICA (2012)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
DNA Methylation As a Clinical Marker in Oncology
Jean-Pierre Issa
JOURNAL OF CLINICAL ONCOLOGY (2012)
Tripartite Motif-Containing Protein 38 Negatively Regulates TLR3/4-and RIG-I-Mediated IFN-β Production and Antiviral Response by Targeting NAP1
Wei Zhao et al.
JOURNAL OF IMMUNOLOGY (2012)
NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy
Kim D. Pruitt et al.
NUCLEIC ACIDS RESEARCH (2012)
Unraveling the Glioma Epigenome-From Molecular Mechanisms to Novel Biomarkers and Therapeutic Targets
Bastian Malzkorn et al.
BRAIN PATHOLOGY (2011)
Cancer epigenetics reaches mainstream oncology
Manuel Rodriguez-Paredes et al.
NATURE MEDICINE (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis
Pan Du et al.
BMC BIOINFORMATICS (2010)
DNA methylation in glioblastoma: impact on gene expression and clinical outcome
Amandine Etcheverry et al.
BMC GENOMICS (2010)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Lonneke A. M. Gravendeel et al.
CANCER RESEARCH (2009)
Use of DNA methylation for cancer detection: Promises and challenges
Jingde Zhu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research
Subha Madhavan et al.
MOLECULAR CANCER RESEARCH (2009)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
分享论文
